Use of Imidazo[1,2-a]pyridine as a Carbonyl Surrogate in a Mannich-Like, Catalyst Free, One-Pot Reaction

Gunaganti Naresh, Naga Rajiv Lakkaniga, Anupreet Kharbanda, Wei Yan, Brendan Frett, Hong Yu Li

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Derivatization of imidazo[1,2-a]pyridine scaffolds have gained considerable attention due to the biological significance of therapeutics based on the imidazopyridine core. By utilizing a catalyst-free, “Mannich type” reaction, we developed a simple and efficient protocol to aminomethylate the C-3 position of imidazo[1,2-a]pyridine through a multicomponent, decarboxylation reaction involving imidazo[1,2-a]pyridine, a secondary amine, and glyoxylic acid. The developed protocol requires mild reaction conditions and furnishes diverse imidazo[1,2-a]pyridine analogues from commercially available starting materials. Additionally, the current protocol improves prior methods, which were limited by the amine substrate scope. Taken together, this current methodology permits rapid diversification of imidazo[1,2-a]pyridines to enhance combinatorial efficiency in the drug discovery processes.

Original languageEnglish (US)
JournalEuropean Journal of Organic Chemistry
DOIs
StateAccepted/In press - Jan 1 2019
Externally publishedYes

Fingerprint

pyridines
catalysts
Catalysts
Amines
amines
decarboxylation
Scaffolds
drugs
imidazo(1,2-a)pyridine
methodology
analogs
acids
Substrates

Keywords

  • Aminomethylation
  • Catalyst-free reaction
  • Heterocycles
  • Mannich bases
  • Multicomponent reactions

ASJC Scopus subject areas

  • Physical and Theoretical Chemistry
  • Organic Chemistry

Cite this

Use of Imidazo[1,2-a]pyridine as a Carbonyl Surrogate in a Mannich-Like, Catalyst Free, One-Pot Reaction. / Naresh, Gunaganti; Lakkaniga, Naga Rajiv; Kharbanda, Anupreet; Yan, Wei; Frett, Brendan; Li, Hong Yu.

In: European Journal of Organic Chemistry, 01.01.2019.

Research output: Contribution to journalArticle

Naresh, Gunaganti ; Lakkaniga, Naga Rajiv ; Kharbanda, Anupreet ; Yan, Wei ; Frett, Brendan ; Li, Hong Yu. / Use of Imidazo[1,2-a]pyridine as a Carbonyl Surrogate in a Mannich-Like, Catalyst Free, One-Pot Reaction. In: European Journal of Organic Chemistry. 2019.
@article{903b7324b9ad4662871714149dbf52f0,
title = "Use of Imidazo[1,2-a]pyridine as a Carbonyl Surrogate in a Mannich-Like, Catalyst Free, One-Pot Reaction",
abstract = "Derivatization of imidazo[1,2-a]pyridine scaffolds have gained considerable attention due to the biological significance of therapeutics based on the imidazopyridine core. By utilizing a catalyst-free, “Mannich type” reaction, we developed a simple and efficient protocol to aminomethylate the C-3 position of imidazo[1,2-a]pyridine through a multicomponent, decarboxylation reaction involving imidazo[1,2-a]pyridine, a secondary amine, and glyoxylic acid. The developed protocol requires mild reaction conditions and furnishes diverse imidazo[1,2-a]pyridine analogues from commercially available starting materials. Additionally, the current protocol improves prior methods, which were limited by the amine substrate scope. Taken together, this current methodology permits rapid diversification of imidazo[1,2-a]pyridines to enhance combinatorial efficiency in the drug discovery processes.",
keywords = "Aminomethylation, Catalyst-free reaction, Heterocycles, Mannich bases, Multicomponent reactions",
author = "Gunaganti Naresh and Lakkaniga, {Naga Rajiv} and Anupreet Kharbanda and Wei Yan and Brendan Frett and Li, {Hong Yu}",
year = "2019",
month = "1",
day = "1",
doi = "10.1002/ejoc.201801430",
language = "English (US)",
journal = "Annalen der Pharmacie",
issn = "0075-4617",
publisher = "Wiley-VCH Verlag",

}

TY - JOUR

T1 - Use of Imidazo[1,2-a]pyridine as a Carbonyl Surrogate in a Mannich-Like, Catalyst Free, One-Pot Reaction

AU - Naresh, Gunaganti

AU - Lakkaniga, Naga Rajiv

AU - Kharbanda, Anupreet

AU - Yan, Wei

AU - Frett, Brendan

AU - Li, Hong Yu

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Derivatization of imidazo[1,2-a]pyridine scaffolds have gained considerable attention due to the biological significance of therapeutics based on the imidazopyridine core. By utilizing a catalyst-free, “Mannich type” reaction, we developed a simple and efficient protocol to aminomethylate the C-3 position of imidazo[1,2-a]pyridine through a multicomponent, decarboxylation reaction involving imidazo[1,2-a]pyridine, a secondary amine, and glyoxylic acid. The developed protocol requires mild reaction conditions and furnishes diverse imidazo[1,2-a]pyridine analogues from commercially available starting materials. Additionally, the current protocol improves prior methods, which were limited by the amine substrate scope. Taken together, this current methodology permits rapid diversification of imidazo[1,2-a]pyridines to enhance combinatorial efficiency in the drug discovery processes.

AB - Derivatization of imidazo[1,2-a]pyridine scaffolds have gained considerable attention due to the biological significance of therapeutics based on the imidazopyridine core. By utilizing a catalyst-free, “Mannich type” reaction, we developed a simple and efficient protocol to aminomethylate the C-3 position of imidazo[1,2-a]pyridine through a multicomponent, decarboxylation reaction involving imidazo[1,2-a]pyridine, a secondary amine, and glyoxylic acid. The developed protocol requires mild reaction conditions and furnishes diverse imidazo[1,2-a]pyridine analogues from commercially available starting materials. Additionally, the current protocol improves prior methods, which were limited by the amine substrate scope. Taken together, this current methodology permits rapid diversification of imidazo[1,2-a]pyridines to enhance combinatorial efficiency in the drug discovery processes.

KW - Aminomethylation

KW - Catalyst-free reaction

KW - Heterocycles

KW - Mannich bases

KW - Multicomponent reactions

UR - http://www.scopus.com/inward/record.url?scp=85059676152&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059676152&partnerID=8YFLogxK

U2 - 10.1002/ejoc.201801430

DO - 10.1002/ejoc.201801430

M3 - Article

AN - SCOPUS:85059676152

JO - Annalen der Pharmacie

JF - Annalen der Pharmacie

SN - 0075-4617

ER -